RenovoRx regains Nasdaq minimum bid price compliance
RenovoRx says it has regained compliance with Nasdaq’s minimum bid price requirement for RNXT.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.